Clinical Trial: A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07873801) titled 'A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis' on Oct. 08.

Brief Summary: The main aim of the study is to evaluate the efficacy and safety of lebrikizumab treatment for up to 32 weeks in participants with moderate-to-severe face and neck atopic dermatitis (FNAD) who also have moderate-to-severe AD outside of the face and neck region, and who are in need of systemic therapy.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis

Intervention: DRUG: Lebrikizumab

Lebrikizumab SC injection.

OTHER: Placebo

Matching placebo SC injection.

DRUG: Lebrikizumab

L...